A new workgroup of the HIT Policy Committee is charged with identifying ways to improve the safety, innovation and regulatory efficiency of health information technology. The group also will compile a report on strategies and recommendations for a risk-based regulatory framework for health I.T., including medical mobile applications.

The Food and Drug Administration Safety Innovation Act Workgroup, authorized under a law of the same name, will advise the FDA, Federal Communications Commission and Office of the National Coordinator for Health Information Technology, reporting through the HIT Policy Committee that advises federal officials.

The workgroup will focus on safety risks--and likelihood--that may be posed by health I.T., factors to be included in a risk-based regulatory approach, and approaches to avoid duplicative or overlapping regulatory requirements. Its first meeting is scheduled on April 29.

A list of workgroup members is available here.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access